Home / Gemcitabine / Czechia
CZ ATC L01BC05 · updated 2 Nov 2026
Gemcitabine shortage in Czechia
Is there a Gemcitabine shortage in Czechia?
Yes. As of 2 Nov 2026, 2 Gemcitabine products are reported short in Czechia, the first since 1 Jan 2026. The company estimate for the return is 13 Nov 2026 (latest 18 Nov 2026). Main reason: manufacturing problem.
Also short in Canada, Germany, France, Italy, Spain, Belgium, Switzerland, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | GEMCITABINE ACCORD 100MG/ML 100MG/ML INF CNC SOL 1X20ML | Accord (Intas) | 1 Jan 2026 | 13 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | GEMCITABIN EBEWE 40MG/ML 40MG/ML INF CNC SOL 1X50ML II | EBEWE Pharma Ges.m.b.H Nfg.KG, Unterach | 2 Sep 2026 | 18 Nov 2026 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.